Windtree offers to cut Series C conversion price to $0.1608, seeks forbearance on claims until April 2025

WINDTREE THERAPEUTICS INC /DE/

Company offered Series C preferred holders conversion price cut to $0.1608; accept by Jan 31, 2025.
Holders signing conversion notice agree to forbear from claims under purchase agreements and related docs through April 30, 2025.
There is no guarantee that any or all holders will accept the offer; conversion and issuance exempt from SEC registration.
Company previously registered resale of up to 27,668,106 shares issuable upon conversion of Series C and exercise of warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.